Clinical trial
Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)
NCT00380705 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00380705 |
|---|---|
| Title | Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365) |
| Official title | Quality of Life in Asthma and Rhinitis Allergic With Singulair |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma, Rhinitis Allergic |
| Intervention type | Drug |
| Interventions | MK0476, Singulair, montelukast sodium / Duration of Treatment: 8 Weeks |
| Enrollment | 91 |
| Start date | Mar 18, 2005 |
| Primary completion | Jul 29, 2005 |
| Completion | Jul 29, 2005 |
| First posted | Sep 26, 2006 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: